Surgeon, writer and public health research Atul Gawande (Balliol 1987) has been named as a member of US President-elect Biden’s Transition COVID-19 Advisory Board. The Board is a team of leading public health experts who will advise the President-elect, Vice President-elect Harris and the Transition’s COVID-19 staff on the country’s response to the pandemic.
Dr Gawande is founder and chair of Ariadne Labs, a joint centre for health systems innovation at Brigham and Women’s Hospital in Boston, Massachusetts, and the Harvard T.H. Chan School of Public Health. His coronavirus work with Ariadne has included scaling COVID-19 testing, demonstrating how other countries have successfully protected healthcare workers, developing tools to guide decision makers with vaccine allocation planning, and managing COVID-19 in surgical systems.
Dr Gawande is Professor in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health and the Samuel O. Thier Professor of Surgery at Harvard Medical School, and he practises general and endocrine surgery at Brigham and Women’s Hospital. He is also the author of a number of books, including the best-selling Being Mortal: Medicine and What Matters in the End (2014) and a staff writer for the New Yorker magazine./p>